Literature DB >> 33444985

Synthesis and in vitro study of nitro- and methoxy-2-phenylbenzofurans as human monoamine oxidase inhibitors.

Giovanna L Delogu1, Amit Kumar2, Gianluca Gatto2, Fernando Bustelo3, Lucía M Saavedra4, Maria Isabel Rodríguez-Franco4, Reyes Laguna5, Dolores Viña6.   

Abstract

A new series of 2-phenylbenzofuran derivatives were designed and synthesized to determine relevant structural features for the MAO inhibitory activity and selectivity. Methoxy substituents were introduced in the 2-phenyl ring, whereas the benzofuran moiety was not substituted or substituted at the positions 5 or 7 with a nitro group. Substitution patterns on both the phenyl ring and the benzofuran moiety determine the affinity for MAO-A or MAO-B. The 2-(3-methoxyphenyl)-5-nitrobenzofuran 9 was the most potent MAO-B inhibitor (IC50 = 0.024 µM) identified in this series, whereas 7-nitro-2-phenylbenzofuran 7 was the most potent MAO-A inhibitor (IC50 = 0.168 µM), both acting as reversible inhibitors. The number and position of the methoxyl groups on the 2-phenyl ring, have an important influence on the inhibitory activity. Molecular docking studies confirmed the experimental results and highlighted the importance of key residues in enzyme inhibition.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  2-Phenylbenzofurans; Docking studies; Monoamine oxidase inhibitors

Year:  2021        PMID: 33444985     DOI: 10.1016/j.bioorg.2020.104616

Source DB:  PubMed          Journal:  Bioorg Chem        ISSN: 0045-2068            Impact factor:   5.275


  3 in total

1.  Design, Synthesis, and Monoamine Oxidase B Selective Inhibitory Activity of N-Arylated Heliamine Analogues.

Authors:  Makito Yamada; Yu Hirose; Bangzhong Lin; Megumi Fumimoto; Kazuto Nunomura; Sirimangkalakitti Natchanun; Naoyuki Takahashi; Yuuta Ohki; Makoto Sako; Kenichi Murai; Kazuo Harada; Masayoshi Arai; Sayo Suzuki; Tomonori Nakamura; Junichi Haruta; Mitsuhiro Arisawa
Journal:  ACS Med Chem Lett       Date:  2022-08-22       Impact factor: 4.632

2.  Resveratrol-Based MTDLs to Stimulate Defensive and Regenerative Pathways and Block Early Events in Neurodegenerative Cascades.

Authors:  Clara Herrera-Arozamena; Martín Estrada-Valencia; Patricia López-Caballero; Concepción Pérez; José A Morales-García; Ana Pérez-Castillo; Eric Del Sastre; Cristina Fernández-Mendívil; Pablo Duarte; Patrycja Michalska; José Lombardía; Sergio Senar; Rafael León; Manuela G López; María Isabel Rodríguez-Franco
Journal:  J Med Chem       Date:  2022-03-04       Impact factor: 7.446

3.  Structural Insight of New Butyrylcholinesterase Inhibitors Based on Benzylbenzofuran Scaffold.

Authors:  Giovanna L Delogu; Antonella Fais; Francesca Pintus; Chinmayi Goyal; Maria J Matos; Benedetta Era; Amit Kumar
Journal:  Pharmaceuticals (Basel)       Date:  2022-03-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.